Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AASK ABPM Pilot Study
NCT00582777Phase 3Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Nov 2007
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ramipril in hypertensive renal disease (3 arms), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Primary endpoint: Night Time Blood Pressure at 18 weeks. Started Nov 2007; status: completed.
02
Drugs
ramipril
03
Conditions
hypertensive renal disease
Beyond the preview
Go deeper on NCT00582777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00582777.